Details of the Drug

General Information of Drug (ID: DMCW7ZL)

Drug Name

RELVARTM or BREOTM ELLIPTATM

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	NDA filed	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	RELVAR ELLIPTA receives regulatory approval in Japan. Theravance. 24 September 2013.